Human chorionic gonadotropin is used clinically in reproductive endocrinology. Observational reports in men exposed to non-prescribed androgens suggest potential fertility-related benefit, but do not justify unsupervised recovery protocols.
Key points
- A case report cannot establish reliable recovery rates.
- Small retrospective data involve medical assessment and selection bias.
- Sperm counts and hormone levels are different outcomes requiring clinical interpretation.
What the literature shows
Gill reported a single case of anabolic-steroid-induced hypogonadism treated with hCG. Its favourable outcome cannot predict recovery for other individuals.
Smit and colleagues retrospectively evaluated sperm outcomes in a small group of men using non-prescribed androgens. Without randomization or a comparison group, improvement cannot be generalized to every pattern of use or guaranteed for any person.
What remains unknown
- Which patients recover without intervention and over what timescale remains variable.
- Optimal management in the context of combined drug use cannot be inferred from a case report or small cohort.
Safety and monitoring implications
- People concerned about fertility or persistent low-testosterone symptoms should seek reproductive or endocrine care and appropriate testing.
- Self-directed treatment may obscure an underlying problem and should not replace a medical evaluation.
Cited literature
- 1.Gill GV. (1998). Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin. Postgraduate Medical Journal. Find on PubMed
- 2.Smit DL, Verdegaal T, Bond P, et al. (2025). Efficacy of human chorionic gonadotropin hormone in restoring spermatogenesis in men using non-prescribed androgens: a retrospective analysis of real-world data. F&S Reports. Find on PubMed
Community reports
Anecdotal — not scientific evidence
Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.
Editorial evidence status
MixedNo independently verified community reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.
Buying Human chorionic gonadotropin / hCG in Australia: what to check first
APEDRA does not sell Human chorionic gonadotropin / hCG or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.
- Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
- Check independent review platforms, not only reviews hosted on the seller's own site.
- Read the shipping, returns and refund policies before ordering.
- Be wary of prices far below the market or exaggerated results claims.
Compare Australian vendors independently · how we assess suppliers
Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.
This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.